comparemela.com

Latest Breaking News On - Thompson institute - Page 7 : comparemela.com

Generous couple put $5m trust in key foundation

Premium Content Subscriber only The region’s most prolific philanthropists have put their trust in a Sunshine Coast foundation dedicated to helping residents in need. Roy and Nola Thompson have announced that the Buderim Foundation has become the trustee for the Roy and Nola Thompson Charitable Trust, which will provide grants to support those experiencing financial distress in the community. Buderim Foundation chair Dr Russell Stitz said while the Thompson Trust would remain a separate fund, it would operate the account as it did other investments. “That is, the investment fund will be preserved in perpetuity with only the revenue being distributed each year,” he said.

First Nations Forum set for March - tickets now available

Sunshine Coast Council A community forum bringing together the voices of First Nations (Aboriginal and Torres Strait Islander) people with a strong focus on fostering relationships, representation and future wellbeing will be a first for the Sunshine Coast and be held at Novotel Twin Waters on Monday 22 March. Sunshine Coast Council is facilitating the event with a forum and dinner, titled First Nations Self-Determination, Representation and Wellbeing, and guest speakers include Kabi Kabi and Jinibara Traditional Custodians, UQ Adjunct Associate Professor and Kombumerri person Dr Mary Graham and Statement from the Heart Working Group First Nations Chair Suzanne Thompson. Ms Thompson said the release of the Uluru Statement from the Heart in 2017 was a defining moment in Australia that had a profound effect.

Ketamine touted as promising mental health treatment

Principal investigator psychiatrist Dr Adem Can said the findings were significant, given the difficulty of treating chronic suicidality. On average, patients experienced a significant reduction in suicide ideation, from a high level before the trial to below the clinical threshold by week six of the trial, Dr Can said. In medicine, this response rate is significant, particularly given it was experienced by patients with chronic suicidality, which can be difficult to treat. These patients had lived with suicidality for a very long time and presented a range of psychiatric conditions, including mood, anxiety and personality disorders, and many of them had lost hope of recovery.

Oral ketamine doses promising against chronic suicidality, study finds

Date Time Oral ketamine doses promising against chronic suicidality, study finds A new study from USC Australia has found that oral doses of ketamine administered in a clinical setting can provide a rapid-acting treatment for chronic suicidality. The study from USC’s Thompson Institute, published in Translational Psychiatry, showed that within the first six weeks, 69 percent of participants achieved a clinical reduction in suicide ideation. Principal investigator psychiatrist Dr Adem Can, who led the research at USC, said the findings were significant, given the difficulty of treating chronic suicidality, and had the potential to save lives. “On average, patients experienced a significant reduction in suicide ideation, from a high level before the trial to below the clinical threshold by week six of the trial,” Dr Can said.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.